Prot #67896062CTP3001: Macitentan in Inoperable or Persistent/Recurrent Chronic ThromboEmbolic Pulmonary Hypertension (MACiTEPH): A Prospective, Randomized, Double-Blind, Multicenter, Placebo-Controlled, Parallel Group, Adaptive Phase 3 Study with Open-l

Project: Research project

Project Details

StatusActive
Effective start/end date9/21/219/18/26

Funding

  • Janssen Research & Development, LLC (Prot #67896062CTP3001)